1. Home
  2. AGIO vs TNK Comparison

AGIO vs TNK Comparison

Compare AGIO & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$37.57

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Teekay Tankers Ltd.

TNK

Teekay Tankers Ltd.

HOLD

Current Price

$75.57

Market Cap

2.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
TNK
Founded
2007
2007
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.5B
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
AGIO
TNK
Price
$37.57
$75.57
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$38.88
$80.00
AVG Volume (30 Days)
1.0M
308.8K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
N/A
2.55%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,011,000.00
N/A
Revenue This Year
$76.75
N/A
Revenue Next Year
$170.73
N/A
P/E Ratio
N/A
$8.05
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$41.77
52 Week High
$46.00
$83.99

Technical Indicators

Market Signals
Indicator
AGIO
TNK
Relative Strength Index (RSI) 52.01 55.86
Support Level $26.71 $70.54
Resistance Level $44.01 $80.29
Average True Range (ATR) 1.69 2.47
MACD -0.77 0.70
Stochastic Oscillator 27.89 77.90

Price Performance

Historical Comparison
AGIO
TNK

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

Share on Social Networks: